BridgeMD
New treatment option for Metastasized Gastro-Oesophageal Cancer
Official title FAZA PETMRI Gastro-Oesophageal Study
ClinicalTrials.gov ID: NCT04560036
What this study is testing
- What it's testing
- This is a single arm, pilot study of PET/MRI scan with radiotracer 18F-Fluoroazomycin Arabinoside (FAZA) before and after standard of care platinum-based chemotherapy for patients with metastasized Gastro-Oesophageal Cancer. Gastroesophageal cancer (GEC) accounted for 2,3000 deaths in Canada in 2017 and majority of the patients present or develop metastatic disease following diagnosis.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Age ≥18 years
- Patients with de novo or secondary metastasized gastro-oesophagesal cancer (adenocarcinoma)
- Glomerular Filtration rate\> 45 ml/min
- No allergy to contrast agents
You likely can't join if
- Contraindication for MR as per current institutional guidelines
- Inability to lie supine for at least 30 minutes
- Any patient who is pregnant or breastfeeding
- Any patient unable or unwilling to provide informed consent
- Patients who are allergic to ethanol as the FAZA preparation contains ethanol
The study team makes the final eligibility decision.
Where it's taking place
- Toronto, Ontario, Canada
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Toronto, Ontario, Canada. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.